Offer - Urjas Oil for just ₹ 1 X
Mflotas Kt is a prescription drug, available for use as Drops. Conjunctivitis are some of its major therapeutic uses. Secondary and off-label uses of Mflotas Kt have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Mflotas Kt. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Mflotas Kt are Eye irritation, Eye itching, Eye Pain. Some other side effects of Mflotas Kt have been listed ahead. Such side effects of Mflotas Kt normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Mflotas Kt has a Unknown effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Mflotas Kt has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Mflotas Kt related warnings section.
Mflotas Kt is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy are examples of such conditions.
Additionally, Mflotas Kt may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Mflotas Kt is not safe while driving, and is not addiction.
Mflotas Kt is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Mflotas Kt safe for pregnant women?
The effects of Mflotas KT on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Mflotas Kt safe during breastfeeding?
There is no research available on the side effects of Mflotas KT in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Mflotas Kt on the Kidneys?
There are no side effects of Mflotas KT on the kidneys.
What is the effect of Mflotas Kt on the Liver?
Mflotas KT is not harmful for the liver.
What is the effect of Mflotas Kt on the Heart?
Using Mflotas KT does not have any harmful effects on the heart.
Mflotas Kt should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Mflotas Kt unless your doctor advises you to do so -
Is this Mflotas Kt habit forming or addictive?
Mflotas Kt is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mflotas Kt can make you feel drowsy.
Is it safe?
Mflotas Kt is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Mflotas Kt is unable to treat or cure mental disorders.
Interaction between Food and Mflotas Kt
It is safe to take Mflotas Kt with food.
Interaction between Alcohol and Mflotas Kt
Due to lack of research, there is no information about the side effects of taking Mflotas Kt with alcohol.
No, Mflotas KT is not safe for a heart. A person taking Mflotas KT has a higher risk of suffering from a heart attack or stroke than the one who doesn't take Mflotas KT. The risk is higher in people who take non-steroidal anti-inflammatory drugs for a long time. Tell your doctor if you or anyone in your family has had a heart attack or a stroke. Tell your doctor if you smoke, you have high blood pressure, diabetes, cholesterol, and bleeding or clotting problems. Consult your doctor immediately if you suffer from shortness of breath and slurred speech.
Yes, Mflotas KT is given for short-term treatment of inflammation and pain, once you find relief from pain and inflammation then you can discontinue it if taken by yourself. But if your doctor has prescribed Mflotas KT and if you are thinking about discontinuing this medicine then do discuss with your doctor.
No, Mflotas KT is not a narcotic. It is a non-steroidal anti-inflammatory drug which is used for the treatment of moderately severe pain. Narcotics are the natural products like opium and its derivatives, heroin, coca leaf and cannabis, synthetic drugs like pethidine, methadone, codeine, morphine. These are also prescription drugs and must be taken cautiously as these can cause an addiction.
Rarely, one can develop an allergic reaction to Mflotas KT. One might feel short of breath and might find it difficult to speak, one might develop a rash or an itch and swell on the lips, face, and throat. If you suffer from any of these symptoms, inform your doctor immediately.
Mflotas KT is a potent, short-acting non-steroidal anti-inflammatory drug. It is extremely important that you follow the instructions of your doctor completely and do not take any extra doses or take it for a longer period of time as that might result in some side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
Product Description [Internet]: MEGACOM™. Sentiss
Product Description [Internet]: MOXIFLOXACIN. FA Davis
Highlights Of Prescribing Information [Internet]: VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% as base Sterile topical ophthalmic solution. USFDA
April Hazard Vallerand, Cynthia A. Sanoski. Davis’s Drug Guide For Nurses. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1404.